OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
KSRP52

Kesar Petroproducts Ltd

Commodity ChemicalsVerified

Kesar Petroproducts Ltd maintains a debt-to-equity ratio of 0.5, indicating a relatively balanced capital structure with moderate leverage. However, the company's liquidity position is assessed as medium, with negative net cash after subtracting total debt, suggesting potential short-term liquidity constraints. The current ratio of 1.83 implies the company has sufficient current assets to cover its current liabilities, but the negative operating cash flow of INR 202.08 million raises concerns about its ability to generate cash from operations. In terms of profitability, the company's return on equity (ROE) of 2.46% and return on assets (ROA) of 1.47% are below the industry median for Commodity Chemicals, indicating underperformance relative to its peers. The operating margin of 1.4% is also below the industry average, suggesting inefficiencies in cost management or pricing power. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or supply chain disruptions. The company's capital expenditures of INR 175.09 million in the latest period suggest ongoing investment in production capacity, but the negative operating cash flow raises questions about the sustainability of such spending. Looking ahead, the company's revenue is projected to grow by 5% in the current fiscal year and 3% in the next fiscal year, based on industry trends and historical performance. However, the modest growth rates and negative operating cash flow suggest that the company may face challenges in maintaining profitability and expanding its market share. The company's risk profile is characterized by medium liquidity risk and low dilution potential. The negative net cash position after debt is a key liquidity flag, and the company has not disclosed any recent share issuance or dilution events. The absence of dilution risk is a positive factor, but the company's reliance on debt financing and negative operating cash flow could lead to increased financial risk in the future. Recent filings and transcripts indicate that the company is focused on cost optimization and improving operational efficiency. The company has also expressed interest in expanding its product portfolio to include higher-margin specialty chemicals. These strategic initiatives could help improve profitability and reduce dependence on commodity chemicals, which are subject to volatile pricing and demand fluctuations.

30-day price · KSRP-0.30 (-1.3%)
Low$20.26High$26.90Close$22.77As of15 May, 00:00 UTC
Profile
CompanyKesar Petroproducts Ltd
TickerKSRP.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Kesar Petroproducts Ltd maintains a debt-to-equity ratio of 0.5, indicating a relatively balanced capital structure with moderate leverage. However, the company's liquidity position is assessed as medium, with negative net cash after subtracting total debt, suggesting potential short-term liquidity constraints. The current ratio of 1.83 implies the company has sufficient current assets to cover its current liabilities, but the negative operating cash flow of INR 202.08 million raises concerns about its ability to generate cash from operations. In terms of profitability, the company's return on equity (ROE) of 2.46% and return on assets (ROA) of 1.47% are below the industry median for Commodity Chemicals, indicating underperformance relative to its peers. The operating margin of 1.4% is also below the industry average, suggesting inefficiencies in cost management or pricing power. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or supply chain disruptions. The company's capital expenditures of INR 175.09 million in the latest period suggest ongoing investment in production capacity, but the negative operating cash flow raises questions about the sustainability of such spending. Looking ahead, the company's revenue is projected to grow by 5% in the current fiscal year and 3% in the next fiscal year, based on industry trends and historical performance. However, the modest growth rates and negative operating cash flow suggest that the company may face challenges in maintaining profitability and expanding its market share. The company's risk profile is characterized by medium liquidity risk and low dilution potential. The negative net cash position after debt is a key liquidity flag, and the company has not disclosed any recent share issuance or dilution events. The absence of dilution risk is a positive factor, but the company's reliance on debt financing and negative operating cash flow could lead to increased financial risk in the future. Recent filings and transcripts indicate that the company is focused on cost optimization and improving operational efficiency. The company has also expressed interest in expanding its product portfolio to include higher-margin specialty chemicals. These strategic initiatives could help improve profitability and reduce dependence on commodity chemicals, which are subject to volatile pricing and demand fluctuations.
Key takeaways
  • Kesar Petroproducts Ltd has a balanced capital structure but faces liquidity constraints due to negative net cash after debt.
  • The company's profitability metrics are below industry medians, indicating underperformance in cost management and pricing.
  • Revenue is concentrated in a single segment with no geographic diversification, increasing exposure to regional risks.
  • The company is projected to grow revenue modestly, but negative operating cash flow raises concerns about sustainability.
  • The company has low dilution risk but faces medium liquidity risk due to its negative net cash position.
  • Strategic initiatives to expand into higher-margin products could improve long-term profitability.
  • --
  • **RATIONALES**:
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$496.1M
Gross profit$84.1M
Operating income$6.9M
Net income$30.7M
R&D
SG&A
D&A
SBC
Operating cash flow-$202.1M
CapEx-$175.1M
Free cash flow
Total assets$2.09B
Total liabilities$843.0M
Total equity$1.24B
Cash & equivalents$46.6M
Long-term debt$628.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.24B-$495.0k$5.0M-$28.2M
FY-3$1.53B$19.8M$26.7M-$5.7M
FY-2$1.20B$5.4M$4.7M-$295.6M
FY-1$1.49B-$13.4M$49.8M-$91.8M
FY0$1.85B$122.2M$99.6M-$26.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$1.52B$1.16B$127.9M
FY-3$1.58B$1.19B$7.1M
FY-2$1.88B$1.19B$36.4M
FY-1$2.09B$1.24B$46.6M
FY0$2.38B$1.44B$138.4M
PeriodOCFCapExFCFSBC
FY-4-$56.1M-$92.6M-$28.2M
FY-3-$56.1M-$92.6M-$5.7M
FY-2$327.1M-$360.6M-$295.6M
FY-1-$202.1M-$175.1M-$91.8M
FY0$131.6M-$163.8M-$26.7M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$496.1M$6.9M$30.7M
FQ-6$458.0M$22.8M$21.2M
FQ-5$487.2M$25.8M$29.2M
FQ-4$496.6M$33.3M$29.4M
FQ-3$409.9M$40.2M$19.8M
FQ-2$495.3M$75.6M$59.0M
FQ-1$502.0M$61.2M$59.2M
FQ0$410.2M$42.8M$29.2M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$2.09B$1.24B$46.6M
FQ-6
FQ-5$2.16B$1.32B$6.9M
FQ-4
FQ-3$2.38B$1.44B$138.4M
FQ-2
FQ-1$2.42B$1.56B$9.4M
FQ0
PeriodOCFCapExFCFSBC
FQ-7-$202.1M-$175.1M
FQ-6
FQ-5-$7.8M-$74.9M
FQ-4
FQ-3$131.6M-$163.8M
FQ-2
FQ-1$158.6M-$216.4M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.24B
Net cash-$581.4M
Current ratio1.8
Debt/Equity0.5
ROA1.5%
ROE2.5%
Cash conversion-6.6%
CapEx/Revenue-35.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricKSRPActivity
Op margin1.4%5.5% medp25 -0.0% · p75 10.8%below median
Net margin6.2%4.1% medp25 0.1% · p75 8.8%above median
Gross margin17.0%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-35.3%-6.2% medp25 -13.4% · p75 -2.6%bottom quartile
Debt / equity50.0%37.1% medp25 10.3% · p75 82.0%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 05:31 UTC#cd1e4067
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 09:08 UTCJob: fb4bbe96